• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of "Moderate Buy" from Brokerages

    ソース: Buzz FX / 03 11 2024 01:41:16   America/Chicago


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat November 3, 2024 Share Link copied to clipboard. Shares of Day One Biopharmaceuticals, Inc.
    Read more...
シェアする